{
    "organizations": [],
    "uuid": "5a774173e9151854154c1cf45acc9ba35735b6bb",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tonix-pharmaceuticals-to-present-f/brief-tonix-pharmaceuticals-to-present-fda-breakthrough-therapy-designated-ptsd-program-at-microcap-conference-idUSFWN1RH04Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Tonix Pharmaceuticals To Present FDA Breakthrough Therapy Designated PTSD Program At Microcap Conference",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 4 (Reuters) - Tonix Pharmaceuticals Holding Corp :\n* DESIGNATED PTSD PROGRAM AT THE MICROCAP CONFERENCE IN NEW YORK\n* INTERIM RESULTS OF HONOR STUDY EXPECTED IN Q3 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-04T19:31:00.000+03:00",
    "crawled": "2018-04-05T17:03:47.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "tonix",
        "pharmaceutical",
        "holding",
        "corp",
        "designated",
        "ptsd",
        "program",
        "microcap",
        "conference",
        "new",
        "york",
        "interim",
        "result",
        "honor",
        "study",
        "expected",
        "q3",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}